Predicting the risk for rheumatoid arthritis with the help of a PET scan.

Phase 1

• Conditions: Rheumatoid arthritis; Therapeutic area: Diseases [C] - Musculoskeletal Diseases [C05]

• Registration Number: EUCTR2018-001114-15-NL
• Lead Sponsor: VU Medical Center, department of Rheumatology

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2018-05-28
• Last Update Posted: 28 February 2019

Recruitment & Eligibility

• Status: Authorised-recruitment may be ongoing or finished
• Sex: Not specified
• Target Recruitment: 60

Inclusion Criteria

1.Patients must be 18 years of age or older
2.Patients must be diagnosed with arthralgia (not secondary to trauma) by a physician
3.Patients must have a positive ACPA blood test
4.Patients must be able to adhere to the study appointments and other protocol requirements.
5.Patients must be capable of giving informed consent and the consent must have been obtained prior to the study related procedures.
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range 60
F.1.3 Elderly (>=65 years) no
F.1.3.1 Number of subjects for this age range

Exclusion Criteria

1.Arthritis and/or tenosynovitis as revealed by physical examination of 44 joints through the Disease Activity Score (DAS) (34) by 2 independent physicians
2.Previous corticosteroid injection in joints
3.Trauma involving joints in the 6 months prior to inclusion
4.Pregnancy or breast-feeding.

Study & Design

• Study Type: Interventional clinical trial of medicinal product
• Study Design: Not specified